Top Markets
Coin of the day
Eucrates Biomedical Acquisition Corp. Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp.

EUCR
Rank in Stocks #26003
Eucrates Biomedical Acquisition Corp. currently lacks substantial business... Eucrates Biomedical Acquisition Corp. currently lacks substantial business operations. Its primary objective is to execute a corporate transaction such as a merger, stock swap, asset purchase, equity acquisition, restructuring, or another comparable strategic alliance involving one or more enterprises. Specifically, it aims to find and acquire a company operating within the life sciences or broader healthcare sectors across North America and Europe. Established in 2020, this entity has its headquarters situated in New York, New York.
Share Price
$10.04
Last synced: 2023-05-05
Market Cap
$44.29M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Eucrates Biomedical Acquisition Corp. (EUCR)
P/E ratio for Eucrates Biomedical Acquisition Corp. (EUCR)
P/E ratio as of 2026 TTM: 0
According to Eucrates Biomedical Acquisition Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for Eucrates Biomedical Acquisition Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.